Latest Asx News

Carnegie Clean Energy has secured significant funding and made key progress in its ACHIEVE Programme, setting the stage for CETO wave energy deployment in the Basque Country in 2025.

Yari Minerals reports promising lithium soil sampling outcomes at its Camel Creek project, identifying 17 anomalous samples out of 347, and resolves a key arbitration, clearing the path for future growth.

Sayona Mining's latest 2024 drilling results at North American Lithium reveal significant high-grade lithium intersections, underscoring potential resource upgrades and expansions in Québec.

Omni Bridgeway Limited reports strong investment proceeds and new commitments in the first half of FY25, alongside significant cost savings and the imminent financial close of Fund 9 with Ares Management.

Alma Metals reports strong drilling results at its Briggs Copper Project, revealing higher-grade copper zones near surface and a promising new mineralisation discovery at the Southern Porphyry Target. The company advances its resource update and mining studies with a solid cash position.

Almonty Industries has locked in final commitments for an AUD 18.45 million equity placement from existing shareholders, aiming to strengthen its financial position and cover offer costs. The placement includes warrants and options, with closing pending regulatory approval.

CuFe Ltd has completed the sale of its JWD iron ore rights and Crossroads gold royalty, while forging a strategic alliance to advance copper and gold projects in Tennant Creek. These moves position the company for focused exploration and development in 2025.

AuMEGA Metals has unveiled plans for a major 2025 drilling program focused on its Bunker Hill project, backed by a successful C$16 million private placement. Recent exploration results highlight promising gold and copper targets across its Newfoundland portfolio.

Titomic Limited has secured AUD 30 million in equity funding and appointed new leadership as it establishes a U.S. headquarters in Huntsville, Alabama, aiming to capitalize on growing aerospace and defense demand.

Paradigm Biopharmaceuticals has appointed Advanced Clinical as the Clinical Research Organisation for its critical Phase 3 trial targeting knee osteoarthritis pain, setting the stage for patient recruitment and dosing in Q2 2025.

Australian Critical Minerals reports significant high-grade iron ore results from its Shaw and Cooletha Projects in the Pilbara, highlighting strong Direct Shipping Ore potential and strategic leadership additions.

First Graphene Limited reports a robust December quarter with new patents, expanded distribution networks, and advancing commercial trials, positioning the company on a path to cash breakeven.